Address Measles Vaccine Concerns and Promote Immunization

You're on the front lines to ensure patients are vaccinated against measles...especially with the recent outbreaks.

It's a big problem in areas with low immunization rates. Explain that 9 out of 10 nonimmune patients will get measles when exposed.

A common scenario is when an unprotected traveler picks up measles while abroad...then spreads it to nonimmune people back home.

Explore vaccine concerns. Remain open to prepared with answers...and put benefits and risks into perspective.

Reassure that numerous studies show MMR and other vaccines DON'T cause autism. And about one in 1,000 patients who get measles will die.

Discourage delaying vaccines. Educate that giving multiple vaccines according to the recommended schedule can't overwhelm the immune system.

Give clear, strong recommendations...and share positive experiences.

For example, saying "I'm fully vaccinated and so are my kids" helps build trust. Use our conversation starter, Vaccine Adherence: Addressing Myths and Hesitancy, to support your discussions and tackle barriers.

Promote appropriate vaccination. Continue to recommend two doses of MMR or MMRV for 12 to 15 months, then at 4 to 6 years.

Make sure kids are protected before traveling to an outbreak area or anywhere outside the U.S. Recommend kids 12 months or older have two MMR doses at least 4 weeks apart...or one MMR dose for infants 6 to 11 months.

But point out that infants who get MMR before one year of age still need two MORE doses per the usual schedule...instead of two doses total.

Ensure adults have had at least ONE dose of MMR if born in 1957 or later. Or give TWO doses at least 4 weeks apart for adults at higher risk of students, healthcare workers, and international travelers. If patients don't have a record of getting MMR, vaccinate.

Don't give MMR to severely immunocompromised or pregnant patients...since it's a live vaccine. Ensure household contacts are vaccinated.

Explain MMR boosters aren't recommended during a measles outbreak. About 97% of people develop lifelong immunity after two doses of a measles vaccine. This differs from mumps, where waning immunity is a concern.

Be alert for measles symptoms, such as fever, the "three Cs"...cough, coryza (runny nose), and conjunctivitis...and a rash starting on the face.

See our chart, Measles FAQs, for answers to common questions.

Key References

  • Ann Intern Med Published online Mar 5, 2019; doi:10.7326/M18-2101
  • MMWR Recomm Rep 2013;62(RR-04):1-34
Pharmacist's Letter. Apr 2019, No. 350401

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.